Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Perspective · 21 Jan 2021Exact title match Conference abstract · 23 Nov 2017 Bioanalytical method development, validation & pharmacokinetics study of 5-Fluorouracil loaded nanoparticles.
stability of the developed 5-fluorouracil nanoparticles (5-FUNPs) and correlates & collects the valuable pharmacokinetics data.5-FUNPs formulated with polymer poly lactic co-glycolic acid with Oil-in-water/solvent…
Conference abstract · 8 May 2017 Molecular modeling a tool for postulating the mechanism of drug interaction: glimepiride alters the pharmacokinetics of sildenafil citrate in diabetic nephropathy animals
The present study evaluates the possible drug interaction between glimepiride (GLIM) and
Conference abstract · 2016 Oxidative damage and pharmacokinetics of the Benzonitrile herbicide, Pendimethalin in rat
oxidative damage and pharmacokinetics of pendimethalin were studied in male rat. Rats were divided into four groups. To conduct the pharmacokinetic study, the 1st group received a single oral dose
Article · 26 Aug 2023 Pharmacokinetic Study of ZandopaÃ?® in Rat Model
goal of this research is to examine the pharmacokinetics of Zandopa® in rats after oral administration of Zandopa® herbal formulation. Acclimatization of rats was done for 7 d before ... cumulative amount excreted was…
Research article · 31 May 2023 Pharmacodynamics and Pharmacokinetics Drug Interactions between ?-Mangostin and Gliclazide: A Pre-Clinical Study
study was conducted to investigate the impact of α-Mangostin on the pharmacodynamics and pharmacokinetics of gliclazide, a widely used drug for type II diabetes. The study was performed ... were observed in normal…
Perspective · 5 Jan 2023 Pharmacokinetic Model to Portray Ciprofloxacin Pharmacokinetics over the Whole Range of Life
Perspective · 22 Nov 2021 Pharmacokinetics and Nonlinear Pharmacokinetic models related to drug
Research article · 24 Aug 2021 Single-Dose, Open-Label, One-Way Pharmacokinetic Studies In The Mexican Population To Evaluate The Bioavailability And Food Effect On The Pharmacokinetics Of 30-mg Extended-Release Nifedipine Tablets
challenge, particularly the development of a once-daily formulation. Therefore, these studies evaluated the pharmacokinetic profile of a new 30-mg Extended-Release Nifedipine Tablets in Mexican population. The…
Conference abstract · 9 Oct 2019 Pharmacokinetic and Pharmacodynamic considerations for drugs binding to alpha-1-acid glycoprotein
reported. Drug binding to plasma proteins can help aid and improve the translation of pharmacokinetic/pharmacodynamic (PK/ PD), safety margin predictions, and relationships from preclinical species to human as well…
Conference abstract · 18 Jul 2018 Studies on pharmacokinetic interactions and toxicity of metformin with glimepiride
treat type 2 diabetes. The present study was carried out to study the pharmacokinetic interactions between these two drugs used in combination. An available RP-HPLC method for simultaneous estimation ... stored at -20ºC…
Conference abstract · 3 Jan 2018 Analytica-2015: Determination of amlodipine in human plasma by liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic & bioequivalence studies - Syed N Alvi - King Faisal Specialist Hospital & Research Centre
analytes were in the worthy range. This strategy can be effectively applied to the pharmacokinetic investigation of AMD, VAL and HCT when given as a polypill.Control of hypertension is significant ... Saudi Arabia. He…
Conference abstract · 2018 Investigation of possible pharmacokinetic interaction between ivabradine and carvedilol in rats using high performance liquid chromatography/mass spectroscopy
congestive heart failure. The aim of this study was to investigate the possibility of pharmacokinetic interaction of a proposed combination of ivabradine and the Ã?²-blocker carvedilol in rats using
Conference abstract · 2018 Quantifying therapeutic peptides in human plasma by mass spectrometry: our experience applied to pharmacokinetic studies in clinical trial
recent experiences in the development and validation of customized bioanalytical methods applied to pharmacokinetic studies included in phase I clinical trials. For the absolute quantitation of these three therapeutic…
Conference abstract · 7 Dec 2017 A Physiologically-based pharmacokinetic model adequately predicted the human pharmacokinetic profiles of YH4808, a novel potassium-competitive acid blocker, to treat gastric acid related diseases
objectives of this study were to develop a human PBPK model optimized by human pharmacokinetic (PK) data, to predict the PK profiles of YH4808 using the PBPK model in various ... Comparison of quantum dot…
Conference abstract · 7 Aug 2017 Simultaneous determination of sofosbuvir, paracetamol and methionine in rat plasma using thin-layer chromatography and its application to pharmacokinetic study
levels exhibited relative standard deviations (RSD)<10%. Freezing-thawing stability was also tested; additionally pharmacokinetic and pharmacodynamics co-relation of the studied drugs in animal model has been done
Conference abstract · 24 Jul 2017 A Sino-African Pharmacokinetic comparison of berberine: the contribution of the intestinal microbiota
African countries, and also as a dietary supplement in many other countries. However, pharmacokinetic (PK) comparisons of berberine in different racial/ethnic groups are lacking. Our study compared
Conference abstract · 8 May 2017 Development of Solid phase extraction and HPLC method for simultaneous estimation Ilaprazole and Glimepiride in rat plasma - Application to pharmacokinetic studies
respectively, in rat plasma. The method was successfully applied in pharmacokinetic studies followed by oral administration of GLM and ILA in rats
Conference abstract · 2017 Development, characterization and pharmacokinetics of olmesartan-loaded solid lipid nanoparticles
Conference abstract · 24 Oct 2016 A new pegylated recombinant E.coli L-asparaginase preparation (MC0609): Comparative pharmacokinetic/pharmacodynamic characterisation in Beagle dog and influence of anti-PEG IgM antibodies on the pharmacokinetics in B6D2F1 mice
coli L-asparaginase (PEG-rASNase MC0609) was designed by medac GmbH (Germany) to improve pharmacokinetic (PK) characteristics of pegylated L-asparaginase in comparison to pegaspargase (OncasparÃ?®) used as first-line…
Conference abstract · 24 Oct 2016 A new pegylated recombinant E.coli L-asparaginase preparation (MC0609): Comparative pharmacokinetic/pharmacodynamic characterisation in Beagle dog and infl uence of anti-PEG IgM antibodies on the pharmacokinetics in B6D2F1 mice
coli L-asparaginase (PEG-rASNase MC0609) was designed by medac GmbH (Germany) to improve pharmacokinetic (PK) characteristics of pegylated L-asparaginase in comparison to pegaspargase (Oncaspar®) used as first-line…
Conference abstract · 18 Jul 2016 Formulation Insulin Nanoparticle Using Chitosan and Pectin Polymers and their pharmacokinetic profile with oral application
Parenteral insulin is one of the major therapeutic for patients with Diabetes
Conference abstract · 18 Jul 2016 Dried Blood Spot Sampling in Combination with LC-MS/MS for Clinical Pharmacokinetic Study and Therapeutic Drug Monitoring
measurement of systemic concentration of compounds used in the assessment and evaluation of pharmacokinetics and therapeutic drug monitoring. As an alternative, dried blood spot (DBS) is an innovative bio-sampling…
Conference abstract · 27 Jun 2016 Recommendations from the AAPS LBABFG Biosimilars Action Program Committee for the Validation Of Pharmacokinetic and Immunogenicity Assays in Support of Biosimilar Drug Development
assays that are able to pick out bioanalytical differences between the Biosimilar and Innovator. Pharmacokinetic and Immunogenicity assays are the major measurement platforms for safety and efficacy data arising from

